Status | Study |
Completed |
Study Name: A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis Condition: Churg-Strauss Syndrome Date: 2013-12-19 Interventions: Biological: Mepolizumab Mepoli |
Recruiting |
Study Name: Pediatric Vasculitis Initiative Condition: Wegeners Granulomatosis (Granulomatosis With Polyangiitis) Microscopic Polyangiitis Date: 2013-11-27 |
Not yet recruiting |
Study Name: PRO Development for ANCA Associated Vasculitis Condition: Wegener Granulomatosis Microscopic Polyangiitis Date: 2012-10-25 |
Recruiting |
Study Name: American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis Condition: Wegener's Granulomatosis Microscopic Polyangiitis Date: 2010-02-09 |
Recruiting |
Study Name: Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides Condition: Wegener's Granulomatosis Churg-Strauss Syndrome Date: 2008-09-11 Interventions: Drug: Methotrexate Drug: Cyclophosphamide |
Completed |
Study Name: Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome Condition: Churg Strauss Syndrome Date: 2008-07-14 Interventions: Drug: mepolizumab 750 mg mepolizumab iv q4wk until week 32 |
Completed |
Study Name: Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome) Condition: MPA PAN or EGPA With FFS=0 At Diagnosis or Within the Firs Date: 2008-03-26 Interventions: Drug: corticosteroid and azathioprine |
Completed |
Study Name: Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss Syndrome Condition: Churg Strauss Syndrome Date: 2007-09-07 Interventions: Biological: Mepolizumab IV mepolizumab, 750 mg Other |
Terminated |
Study Name: Rituxan in Churg Strauss Syndrome With Renal Involvement Condition: Churg-Strauss Syndrome Date: 2007-01-19 Interventions: Drug: Rituximab Patients recei |
Completed |
Study Name: CHUSPAN SCS BP Treatment of Churg–Strauss Syndrome Without Poor-Prognosis Factors Condition: Churg-Strauss Syndrome Date: 2006-11-13 Interventions: Drug: azathioprine Drug: cyclophosphamide |